GCP
BHVN icon

GSA Capital Partners’s Biohaven BHVN Stock Holding History

GSA Capital Partners’s Portfolio BHVN Stock Details BHVN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-116,798
Closed -$988K – 1757
2026
Q1 		$988K Buy
116,798
+47,753
+69% +$522K 0.06% 503
2025
Q4 		$780K Buy
+69,045
New +$855K 0.07% 509
2025
Q3 		– Sell
-16,574
Closed -$234K – 1658
2025
Q2 		$234K Sell
16,574
-1,615
-9% -$28.8K 0.02% 1414
2025
Q1 		$437K Buy
18,189
+7,576
+71% +$267K 0.04% 893
2024
Q4 		$396K Buy
10,613
+6,004
+130% +$280K 0.03% 1047
2024
Q3 		$230K Sell
4,609
-11,124
-71% -$433K 0.02% 1359
2024
Q2 		$546K Buy
15,733
+1,732
+12% +$68.5K 0.04% 901
2024
Q1 		$766K Buy
+14,001
New +$693K 0.06% 622
2023
Q4 		– Sell
-35,490
Closed -$923K – 1515
2023
Q3 		$923K Buy
+35,490
New +$738K 0.08% 446

Other funds holding BHVN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
Stifel Financial
Stifel Financial St. Louis, Missouri $120B AUM 27.84% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
IAM
Infinitum Asset Management Fort Lauderdale, Florida $983M AUM 26.53% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

GSA Capital Partners's BHVN Position: Q2 2026 in Review

GSA Capital Partners sold out of Biohaven (BHVN) in Q2 2026, closing a stake of 116,798 shares — an estimated $988K sold.

GSA Capital Partners first reported a position in BHVN in Q3 2023 and held it in 9 quarters. The position peaked at $988K in Q1 2026. 296 funds tracked by Wall St. Rank hold BHVN as of Q2 2026.

  • GSA Capital Partners reported no remaining Biohaven position as of Q2 2026 after selling out during the quarter.
  • GSA Capital Partners sold 116,798 Biohaven shares in Q2 2026, an estimated $988K.
  • GSA Capital Partners first reported a position in Biohaven in Q3 2023 and held it in 9 quarters.
  • GSA Capital Partners's Biohaven position peaked at $988K in Q1 2026.
  • 296 funds tracked by Wall St. Rank held Biohaven as of Q2 2026.

Based on GSA Capital Partners's 13F filing for Q2 2026, filed 6 Aug 2026.